Ola Nilsson Selected Research

PHEX Phosphate Regulating Neutral Endopeptidase

1/2019	FGF23 and its role in X-linked hypophosphatemia-related morbidity.
1/2019	Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ola Nilsson Research Topics

Disease

47	Neoplasms (Cancer) 08/2021 - 01/2002
13	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2019 - 08/2002
10	Carcinoid Tumor (Carcinoid) 02/2012 - 04/2004
8	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2002
6	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020 - 09/2006
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2011 - 08/2003
4	Rickets (Rachitis) 01/2022 - 01/2019
3	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2022 - 01/2019
3	Melanoma (Melanoma, Malignant) 08/2021 - 10/2014
3	Growth Disorders 08/2020 - 10/2013
3	Thyroid Neoplasms (Thyroid Cancer) 01/2012 - 01/2005
3	Hypothyroidism 01/2011 - 04/2008
3	Pheochromocytoma 08/2006 - 01/2002
2	Congenital Abnormalities (Deformity) 01/2022 - 01/2021
2	Abscess 01/2022 - 01/2019
2	Pain (Aches) 01/2021 - 01/2019
2	Osteoarthritis 08/2020 - 01/2019
2	medullary Thyroid cancer 01/2020 - 01/2019
2	Hypertrophy 11/2016 - 05/2002
2	Brain Ischemia (Cerebral Ischemia) 01/2013 - 01/2011
1	Lung Neoplasms (Lung Cancer) 08/2021
1	Hyperplasia 01/2021
1	Infections 01/2021
1	Fatigue 01/2021
1	Achondroplasia 01/2021
1	Microcephaly 10/2020
1	Osteochondritis Dissecans 08/2020
1	Uveal melanoma 01/2019
1	Enthesopathy 01/2019
1	Osteomalacia 01/2019
1	Hypophosphatemia 01/2019

Drug/Important Bio-Agent (IBA)

15	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2019 - 07/2002
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2004
8	Radioisotopes (Radionuclides)IBA 04/2018 - 08/2006
8	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2017 - 04/2004
7	Tyrosine Kinase InhibitorsIBA 01/2020 - 06/2007
5	Therapeutic UsesIBA 01/2020 - 04/2004
5	177Lu-octreotateIBA 03/2019 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 04/2018 - 10/2014
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2012 - 08/2003
4	Tyr(3)- octreotateIBA 02/2012 - 08/2003
3	burosumabIBA 01/2022 - 01/2019
3	Phosphates (Orthophosphate)IBA 01/2022 - 01/2019
3	RNA (Ribonucleic Acid)IBA 03/2019 - 08/2017
3	Biological ProductsIBA 04/2018 - 01/2002
3	Imatinib Mesylate (Gleevec)FDA Link 08/2017 - 04/2009
3	Octreotide (Sandostatin)FDA LinkGeneric 02/2008 - 08/2004
3	Chromogranin AIBA 02/2008 - 08/2004
3	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 09/2007 - 04/2004
2	Vitamin D FDA LinkGeneric 01/2022 - 01/2021
2	Alkaline PhosphataseIBA 01/2022 - 01/2019
2	Phosphorus (Red Phosphorus)IBA 01/2021 - 01/2019
2	Monoclonal AntibodiesIBA 01/2021 - 01/2002
2	Fibroblast Growth Factor-23IBA 01/2021 - 01/2019
2	Aggrecans (Aggrecan)IBA 08/2020 - 08/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2013
2	PHEX Phosphate Regulating Neutral EndopeptidaseIBA 01/2019 - 01/2019
2	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 01/2017 - 01/2005
2	Peptide Receptors (Peptide Receptor)IBA 01/2017 - 05/2013
2	indium-111-octreotideIBA 05/2013 - 07/2002
2	Serotonin (5 Hydroxytryptamine)IBA 01/2013 - 01/2011
2	Angiotensin IIIBA 01/2013 - 01/2011
2	Endothelins (Endothelin)IBA 01/2013 - 01/2011
2	Propylthiouracil FDA Link 04/2009 - 04/2008
2	SynaptophysinIBA 06/2008 - 06/2007
2	Peptides (Polypeptides)IBA 01/2008 - 04/2004
2	Cadherins (E-Cadherin)IBA 06/2007 - 01/2002
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 06/2007 - 01/2002
2	3-Iodobenzylguanidine (Iobenguane)IBA 08/2006 - 08/2006
2	RadiopharmaceuticalsIBA 04/2005 - 07/2002
2	AntibodiesIBA 04/2004 - 01/2002
1	SaltsIBA 01/2022
1	Smad4 ProteinIBA 01/2021
1	vosoritideIBA 01/2021
1	VaccinesIBA 01/2021
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2021
1	Growth Hormone (Somatotropin)IBA 10/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2020
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2019
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Gemcitabine FDA Link 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2019
1	CytokinesIBA 01/2019
1	CateninsIBA 01/2018
1	4-nitrophenylphosphorylcholine (NPPC)IBA 01/2018
1	Apolipoproteins E (ApoE)IBA 01/2018

Therapy/Procedure

24	Therapeutics 01/2022 - 04/2004
5	Radiotherapy 05/2013 - 04/2004
4	Liver Transplantation 09/2007 - 08/2002
2	Immunotherapy 08/2021 - 01/2019
2	Transplantation 12/2015 - 03/2007
2	Drug Therapy (Chemotherapy) 06/2010 - 08/2006
2	Palliative Care (Palliative Therapy) 01/2008 - 04/2004
2	Injections 10/2007 - 09/2004
2	Adrenalectomy 08/2006 - 08/2006
1	Ligation 10/2020
1	Neoadjuvant Therapy 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019